86400-51-3

Basic information

• Product Name: Benzoic acid, 3-(bromomethyl)-4-nitro-, ethyl ester
• CAS NO: 86400-51-3
• Molecular Formula: C10H10BrNO4
• Molecular Weight: 288.098
• Mol File: 86400-51-3.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 3-(bromomethyl)-4-nitro-, ethyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 3-(bromomethyl)-4-nitro-, ethyl ester(86400-51-3)
• EPA Substance Registry System: Benzoic acid, 3-(bromomethyl)-4-nitro-, ethyl ester(86400-51-3)

Safety Data

• Hazardous Substances Data: 86400-51-3(Hazardous Substances Data)

Upstream product

• 30650-90-9 3-methyl-4-nitro-benzoic acid ethyl ester 

Downstream Products

• 851203-01-5 3-methoxymethyl-4-nitro-benzoic acid methyl ester 
• 219763-61-8 ethyl 4-acetylamino-3-(2,4-dichlorobenzylamino)methylbenzoate 
• 1018809-04-5 C₂₄H₃₁N₃O₇ 
• 219763-60-7 ethyl 3-(2,4-dichlorobenzylamino)methyl-4-nitrobenzoate hydrochloride 
• 86413-23-2 3,6-dicarbethoxy-3-benzyl-3,4-dihydro-quinolin-2(1H)-one 
• 86400-56-8 3-benzyl-6-chloromethyl-8-nitro-3,4-dihydro-quinolin-2(1H)-one 
• 86400-53-5 3-benzyl-3,4-dihydro-quinolin-2(1H)-one-6-carboxylic acid 
• 86400-54-6 3-benzyl-6-hydroxymethyl-3,4-dihydro-quinolin-2(1H)-one 
• 86400-55-7 3-benzyl-6-chloromethyl-3,4-dihydro-quinolin-2(1H)-one 
• 412318-01-5 2-nitro-5-(allyloxycarbonyl)benzyl 4-nitrophenyl carbonate 
• 412318-00-4 3-hydroxymethyl-4-nitrobenzoic acid allyl ester 
• 840531-38-6 ethyl 3-({3-[amino(imino)methyl]phenoxy}methyl)-4-{[4-(4-methyl-1,4-diazepan-1-yl)benzoyl]amino}benzoate 
• 840531-22-8 ethyl 3-[(3-cyanophenoxy)methyl]-4-{[4-(4-methyl-1,4-diazepan-1-yl)benzoyl]amino}benzoate 
• 840531-19-3 ethyl 3-[(3-cyanophenoxy)methyl]-4-nitrobenzoate 

Relevant articles and documents

Design, synthesis and biological evaluation of novel substituted benzoylguanidine derivatives as potent Na+/H+ exchanger inhibitors

A novel series of substituted benzoylguanidine derivatives were designed and synthesized as potent NHE1 inhibitors. Most compounds can significantly inhibit NHE1-mediated platelet swelling in a concentration-dependent manner, among which compound 5f (ICs

Synthesis and biological activity of novel 1,2-disubstituted benzene derivatives as factor Xa inhibitors

Factor Xa (fXa) is a serine protease that plays a pivotal role in the coagulation cascade. High-throughput screening of the Yamanouchi compound library yielded lead compound 1 with the ability to inhibit fXa at micromolar concentrations. To improve its fX

Sulfonamide compounds and medicinal use thereof

A sulfonamide compound of the formula (I):R 1 --SO 2 NHCO--A--R 2 (I)wherein R 1 is alkyl, alkenyl, alkynyl and the like; A is an optionally substituted heteropolycyclic group except benzimidazolyl, indolyl, 4,7-dihydrobenzimidazolyl and 2,3-dihydrobenzoxazinyl; X is alkylene, oxa, oxa(lower)alkylene and the like; and R 2 is optionally substituted aryl, substituted biphenylyl and the like, a salt thereof and a pharmaceutical composition comprising the same. The sulfonamide compound is effective for the diseases treatable based on their blood sugar level-depressing activity, cGMP-PDE (especially PDE-V)-inhibiting activity, smooth muscle relaxing activity, bronchodilating activity, vasodilating activity, smooth muscle cell suppressing activity, and antiallergic activity.